References

Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol. 2013; 169:91-97 https://doi.org/10.1111/bjd.12526

Alsan M, Garrick O, Graziani G. Does diversity matter for health?. Experimental evidence from Oakland. 2018; 109:(12)4071-4111

Basit H, Godse KV, Al Aboud AM. Melasma.Treasure Island (FL): Statpearls Publishing; 2020

Battie C, Gohara M, Verschoore M, Roberts W. Skin cancer in skin of color: an update on current facts, trends, and misconceptions. J Drugs Dermatol. 2013; 12:(2)194-198

Battle EF. Advances in laser hair removal in skin of color. J Drugs Dermatol. 2011; 10:(11)1235-1239

Boer M, Duchnik E, Maleszka R, Marchlewicz M. Structural and biophysical characteristics of human skin in maintaining proper epidermal barrier function. Postepy Dermatol Alergol. 2016; 33:(1)1-5 https://doi.org/10.5114%2Fpdia.2015.48037

Bolanca I, Bolanca Z, Kuna K Chloasma—the mask of pregnancy. Coll Antropol. 2008; 32:139-141

Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 2008; 84:(3)539-549 https://doi.org/10.1111/j.1751-1097.2007.00226.x

Cestari TF, Dantas LP, Boza JC. Acquired hyperpigmentations. An Bras Dermatol. 2014; 89:(1)11-25 https://doi.org/10.1590/abd1806-4841.20142353

Cohen BE, Elbuluk N. Microneedling in skin of color: a review of uses and efficacy. J Am Acad Dermatol. 2016; 74:(2)348-355 https://doi.org/10.1016/j.jaad.2015.09.024

Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010; 3:(7)20-31

Melanocyte and pigmentation. 2011. https://biologiedelapeau.fr/spip.php?article7 (accessed 13 January 2020)

Feng L, Hawkins S. Reduction of “ashiness” in skin of color with a lipid-rich moisturizing body wash. J Clin Aesthet Dermatol. 2011; 4:(3)41-44

Garcia MS, Azari R, Eisen DB. Treatment of dermatosis papulosa nigra in 10 patients: a comparison trial of electrodesiccation, pulsed dye laser, and curettage. Dermatol Surg. 2010; 36:(12)1968-1972 https://doi.org/10.1111/j.1524-4725.2010.01769.x

Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011; 17:(1–2)113-125 https://doi.org/10.2119%2Fmolmed.2009.00153

Green BA, Yu RJ, Van Scott EJ. Clinical and cosmeceutical uses of hydroxyacids. Clin Dermatol. 2009; 27:(5)495-501 https://doi.org/10.1016/j.clindermatol.2009.06.023

Grimes PE, Miller MM. Vitiligo: Patient stories, self-esteem, and the psychological burden of disease. Int J Womens Dermatol. 2018; 4:(1)32-37 https://doi.org/10.1016%2Fj.ijwd.2017.11.005

Grimes PE, Ijaz S, Nashawati R, Kwak D. New oral and topical approaches for the treatment of melasma. Int J Womens Dermatol. 2019; 5:(1)30-36 https://doi.org/10.1016%2Fj.ijwd.2018.09.004

Gupta AK, Bharadwaj M, Mehrota R. Skin cancer concerns in people of color: risk factors and prevention. Asian Pac J Cancer Prev. 2016; 17:(12)5257-5264 https://doi.org/10.22034%2FAPJCP.2016.17.12.5257

Guss L, Bolton JG, Fabi SG. Combination therapy in skin of color including injectables, laser, and light devices. Seminars in Cutaneous Medicine and Surgery. 2016; 35:211-217 https://doi.org/10.12788/j.sder.2016.059

Hunter ML. Buying racial capital: skin-bleaching and cosmetic surgery in a globalized world. J Pan African Studies. 2011; 4:(4)142-164

Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician. 2009; 80:(3)253-260

Kang HY, Ortonne JP. What should be considered in treatment of melasma. Ann Dermatol. 2010; 22:(4)373-378 https://doi.org/10.5021/ad.2010.22.4.373

Kang SJ, Davis SA, Feldman SR, McMichael AJ Dyschromia in skin of color. J Drugs Dermatol. 2014; 13:(4)401-406

Kennedy BM, Rehman M, Johnson WD, Magee MB, Leonard R, Katzmarzyk PT. Healthcare providers versus patients' understanding of health beliefs and values. Patient Exp J. 2017; 4:(3)29-37

The future of the world's population in 4 charts. 2015. https://blogs.worldbank.org/opendata/future-world-s-population-4-charts (accessed 13 January 2020)

Kornhauser A, Coelho SG, Hearing VJ. Effects of cosmetic formulations containing hydroxyacids on sun-exposed skin: current applications and future developments. Dermatol Res Pract. 2012; 8 https://doi.org/10.1155%2F2012%2F710893

La Ruche G, Cesarini JP. Histology and physiology of black skin. Ann Dermatol Venereol. 1992; 119:(8)567-574

Skin whiteners are still in demand, despite health concerns. 2018. https://edition.cnn.com/2018/09/02/health/skin-whitening-lightening-asia-intl/index.html (accessed 13 January 2020)

Lupo MP. Dermatosis papulosis nigra: treatment options. J Drugs Dermatol. 2007; 6:(1)29-30

Mari W, Alsabri SG, Tabal N, Younes S, Sherif A, Simman R. Novel insights on understanding of keloid scar: article review. J A Coll Clin Wound Spec. 2016; 7:(1–3)1-7 https://doi.org/10.1016/j.jccw.2016.10.001

McGinty S, Siddiqui WJ. Keloid.Treasure Island (FL): StatPearls Publishing; 2020

Nguyen TA, Patel PS, Viola KV, Friedman AJ. Pseudofolliculitis barbae in women: a clinical perspective. Br J Dermatol. 2015; 173:(1)279-281 https://doi.org/10.1111/bjd.13644

Niang SO, Kane A, Diallo M, Choutah F, Dieng MT, Ndiaye B. Dermatosis papulosa nigra in Dakar, Senegal. Int K Dermatol. 2007; 46:45-47 https://doi.org/10.1111/j.1365-4632.2007.03465.x

Ogawa R, Akaishi S, Kuribayashi S, Miyashita T. Keloids and hypertrophic scars can now be cured completely: recent progress in our understanding of the pathogenesis of keloids and hypertrophic scars and the most promising current therapeutic strategy. J Nippon Med Sch. 2016; 83:(2)46-53 https://doi.org/10.1272/jnms.83.46

Ogunbiyi A. Pseudofolliculitis barbae; current treatment options. Clin Cosmet Investig Dermatol. 2019; 12:241-247 https://doi.org/10.2147%2FCCID.S149250

Pichaimuthu R, Ramaswamy P, Bikish K, Joseph R. A measurement of the stigma among vitiligo and psoriasis patients in India. Indian J Dermatol Venereol Leprol. 2011; 77:(3)300-306 https://doi.org/10.4103/0378-6323.79699

Paying a high price for skin bleaching. 2019. https://www.un.org/africarenewal/magazine/april-2019-july-2019/paying-high-price-skin-bleaching (accessed 13 January 2020)

Roberts WE, Henry M, Burgess C, Saedi N, Chilukuri S, Campbell-Chambers A. Laser treatment of skin of color for medical and aesthetic uses with a new 650-microsecond Nd:YAG 1064nm laser. J Drugs Dermatol. 2019; 18:(4)s135-s137

Salam A, Dadzie OE, Galadari H. Chemical peeling in ethnic skin: an update. Br J Dermatol. 2013; 169:82-90 https://doi.org/10.1111/bjd.12535

Sarkar R, Arora P, Garg VK. Cosmeceuticals for hyperpigmentation: what is available?. J Cutan Aesthet Surg. 2013; 6:(1)4-11 https://doi.org/10.4103%2F0974-2077.110089

Sarkar R, Arora P, Garg VK, Sonthalia S, Gokhale N. Melasma update. Indian Dermatol Online J. 2014; 5:(4)426-435 https://doi.org/10.4103%2F2229-5178.142484

Singh A, Yadav S. Microneedling: advances and widening horizons. Indian Dermatol. 2016; 7:(4)244-254 https://doi.org/10.4103%2F2229-5178.185468

Talakoub L, Wesley NO. Differences in perceptions of beauty and cosmetic procedures performed in ethnic patients. Semin Cutan Med Surg. 2009; 28:(2)115-129 https://doi.org/10.1016/j.sder.2009.05.001

Sugaring hair removal 101. 2019. https://www.byrdie.com/sugaring-hair-removal-101-1717097 (accessed 13 January 2020)

Vashi NA, De Castro Maymone MB, Kundu RV. Aging differences in ethnic skin. J Clin Aesthet Dermatol. 2016; 9:(1)31-38

Viera MH, Caperton CV, Berman B. Advances in the treatment of keloids. J Drugs Dermatol. 2011; 10:(5)468-480

Wan DC, Wong VW, Longaker MT, Yang GP, Wei FC. Moisturizing different racial skin types. J Clin Aesthet Dermatol. 2014; 7:(6)25-32

Xiao A, Ettefagh L. Dermatosis papulosa nigra.Treasure Island (FL): Statpearls Publishing; 2020

Understanding the needs of skin of colour

02 March 2020
Volume 9 · Issue 2

Abstract

The skin of colour population is rising globally and practitioners are faced with an increasingly diverse footfall. Additionally, there are also increased demands for inclusivity in a vastly multi-cultural world. To satisfy these societal changes, it is important for practitioners to be competent in meeting the needs of all patient groups.

From understanding the physiology of skin of colour to an appreciation of how culture, myths and expectations impact the conditions presented, as well as product and treatment selection, practitioners today need greater awareness to provide a superior and profitable service that meets the needs of all patients and stakeholders.

In an age of easy global travel and increasingly diverse populations, it is crucial for practitioners to understand the varying needs of different ethnic demographics and also to be able to offer services that successfully treat patients' skincare concerns.

Africa is the fastest growing region and, together with Asia, it will account for over 80% of the world population (Khokhar and Kashiwase, 2015). This means that the worldwide white population is falling, and in the UK this is confirmed by the last census in 2011, which showed that the white British population had fallen in the preceding ten years by 7%, whereas BAME and mixed ethnicity demographic is on the increase (Gov.co.uk, 2018).

With this expected growth in diversity comes the opportunity for aesthetic practitioners to strengthen their service provision by ensuring their understanding of skin of colour is strong and up to date, as well as appreciating the factors that are important to the populations they treat (Talakoub and Wesley, 2009).

Register now to continue reading

Thank you for visiting Journal of Aesthetic Nurses and reading some of our peer-reviewed resources for aesthetic nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month